Human serum albumin: Isoforms and analbuminemia;Humant serumalbumin: Isoformer og analbuminæmi

Ugeskrift for Laeger

Volumn 170, Issue 19, 2008, Pages 1638-1643

  Kragh Hansen, Ulrich ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; LIGAND; SERUM ALBUMIN;

BLOOD; CHEMISTRY; ELECTROPHORESIS; GENETIC VARIABILITY; GENETICS; HOMOZYGOTE; HUMAN; HYPERTHYROXINEMIA; IMMUNOLOGY; ISOMERISM; METABOLISM; REVIEW;

ELECTROPHORESIS, CELLULOSE ACETATE; HOMOZYGOTE; HUMANS; HYPERTHYROXINEMIA; ISOMERISM; LIGANDS; PROTEIN ISOFORMS; SERUM ALBUMIN; VARIATION (GENETICS);

EID: 44449130964     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Song Y-H, Naumova AK, Liebhaber SA et al. Physical and meiotic mapping of the region of human chromosome 4q11-q13 encompassing the vitamin D binding protein DBP/Gc-globulin and albumin multigene cluster. Genome Res 1999;9:581-7.
2. Petersen CE, Scottolini AG, Cody LR et al. A point mutation in the human serum albumin gene results in familial dysalbuminaemic hyperthyroxinaemia. J Med Genet 1994;31:355-9.
3. Sunthornthepvarakul T, Angkeow P, Weiss RE et al. An identical missense mutation in the albumin gene results in familial dysalbuminemic hyperthyroxinemia in 8 unrelated families. Biochem Biophys Res Commun 1994;202:781-7.
4. Pannain S, Feldman M, Eiholzer U et al. Familial dysalbuminemic hyperthyroxinemia in a Swiss family caused by a mutant albumin (R218P) shows an apparent discrepancy between serum concentration and affinity for thyroxine. J Clin Endocrinol Metab 2000;85:2786-92.
5. AvRuskin TW, Juan CS, Weiss RE. Familial dysalbuminemic hyperthyroxinemia: a rare example of albumin polymorphism and its rapid molecular diagnosis. J Pediatr Endocrinol Metab 2002;15:801-7.
6. Tang K-T, Yang H-J, Choo K-B et al. A point mutation in the albumin gene in a Chinese patient with familial dysalbuminemic hyperthyroxinemia. Eur J Endocrinol 1999;141:374-8.
7. Tiu SC, Choi KL, Shek CC et al. A Chinese family with familial dysalbuminaemic hyperthyroxinaemia. Hong Kong Med J 2003;9:464-7.
8. Wada N, Chiba H, Shimizu C et al. A novel missense mutation in codon 218 of the albumin gene in a distinct phenotype of familial dysalbuminemic hyperthyroxinemia in a Japanese kindred. J Clin Endocrinol Metab 1997;82:3246-50.
9. Hartling UB, Nielsen TL, Brøns M. Familiær dysalbuminæmisk hypertyroksinæmi. Ugeskr Læger 2005;167:300-1.
10. Petitpas I, Petersen CE, Ha C-E et al. Structural basis of albumin-thyroxine interactions and familial dysalbuminemic hyperthyroxinemia. Proc Natl Acad Sci USA 2003;100:6440-5.
11. Kragh-Hansen U, Watanabe H, Nakajou K et al. Chain length-dependent binding of fatty acid anions to human serum albumin studied by site-directed mutagenesis. J Mol Biol 2006;363:702-12.
12. Petersen CE, Ha C-E, Harohalli K et al. Familial dysalbuminemic hyperthyroxinemia may result in altered warfarin pharmacokinetics. Chem Biol Interact 2000;124:161-72.
13. Watanabe H, Kragh-Hansen U, Tanase S et al. Conformational stability and warfarin-binding properties of human serum albumin studied by recombinant mutants. Biochem J 2001;357:269-74.
14. Petersen CE, Ha C-E, Harohalli et al. Mutagenesis studies of thyroxine binding to human serum albumin define an important structural characteristic of subdomain 2A. Biochemistry 1997;36:7012-7.
15. Sunthornthepvarakul T, Likitmaskul S, Ngowngarmratana S et al. Familial dysalbuminemic hypertriiodothyroninemia: a new, dominantly inherited albumin defect. J Clin Endocrinol Metab 1998;83:1448-54.
16. Failla ML, van de Veerdonk M, Morgan WT et al. Characterization of zinc-binding proteins of plasma in familial hyperzincemia. J Lab Clin Med 1982;100:943-52.
17. Minchiotti L, Campagnoli M, Rossi A et al. A nucleotide insertion and frame-shift cause albumin Kénitra, an extended and O-glycosylated mutant of human serum albumin with two additional disulfide bridges. Eur J Biochem 2001;268:344-52.
18. Kragh-Hansen U. Structural and functional aspects of genetic variants of human serum albumin and pro-albumin. Current Topics Mol Pharmacol 1993; 1:1-10.
19. Madison J, Galliano M, Watkins S et al. Genetic variants of human serum albumin in Italy: point mutants and a carboxyl-terminal variant. Proc Natl Acad Sci USA 1994;91:6476-80.
20. Tárnoky AL. Genetic and drug-induced variation in serum albumin. Adv Clin Chem 1980;21:101-46.
21. Peters T Jr. All about albumin: biochemistry, genetics, and medical applications. San Diego: Academic Press, 1996.
22. Brennan SO, Myles T, Peach RJ et al. Albumin Redhill (-1 Arg, 320 Ala → Thr): a glycoprotein variant of human serum albumin whose precursor has an aberrant signal peptidase cleavage site. Proc Natl Acad Sci USA 1990;87:26-30.
23. The albumin website. Findes på: www.albumin.org /maj 2007.
24. Galliano M, Kragh-Hansen U, Tárnoky AL et al. Genetic variants showing apparent hot-spots in the human serum albumin gene. Clin Chim Acta 1999;289:45-55.
25. Doumas BT, Peters T Jr. Serum and urine albumin: a progress report on their measurement and clinical significance. Clin Chim Acta 1997;258:3-20.
26. Nielsen H, Kragh-Hansen U, Minchiotti L et al. Effect of genetic variation on the fatty acid-binding properties of human serum albumin and proalbumin. Biochim Biophys Acta 1997;1342:191-204.
27. Minchiotti L, Kragh-Hansen U, Nielsen H et al. Structural characterization, stability and fatty acid-binding properties of two French genetic variants of human serum albumin. Biochim Biophys Acta 1999;1431:223-31.
28. Kragh-Hansen U, Campagnoli M, Dodig S et al. Structural analysis and fatty acid-binding properties of two Croatian variants of human serum albumin. Clin Chim Acta 2004;349:105-12.
29. Kragh-Hansen U. Humant serumalbumin: nyt om en gammel bekendt. Ugeskr Læger 2007;169:3467-70.
30. Peach RJ, Brennan SO. Structural characterization of a glycoprotein variant of human serum albumin: albumin Casebrook (494 Asp → Asn). Biochim Biophys Acta 1991;1097:49-54.
31. 2+ to natural mutants of human serum albumin and proalbumin. Biochem J 1994;301:217-23.
32. Campagnoli M, Kragh-Hansen U, Pedersen AO et al. Structural analysis, fatty acid and thyroxine binding properties of Vancouver and Naskapi variants of human serum albumin. Clin Biochem 2003;36:597-605.
33. Vestberg K, Galliano M, Minchiotti L et al. High-affinity binding of warfarin, salicylate and diazepam to natural mutants of human serum albumin modified in the C-terminal end. Biochem Pharmacol 1992;44:1515-21.
34. Naylor DH, Anhorn CA, Laschinger C et al. Antigenic differences between normal human albumin and a genetic variant. Transfusion 1982;22:128-33.
35. Kandle SK, Murthy YVSA, Naikwadi AR et al. A case of bisalbuminaemia with immunological studies on albumin variant. J Indian Med Assoc 1996;94:31-3.
36. Campagnoli M, Rosipal S, Debreova M et al. Analbuminemia in a Slovak Romany (gypsy) family: case report and mutational analysis. Clin Chim Acta 2006;365:188-93.
37. Peters T Jr, Holowachuk EW, McIncrow R et al. Albumin locust valley: a new case of analbuminemia. Clin Biochem 2006;39:904-6.
38. Watkins S, Madison J, Galliano M et al. Analbuminemia: three cases resulting from different point mutations in the albumin gene. Proc Natl Acad Sci USA 1994;91:9417-21.